RPMB predicts the disease-free survival of head-and-neck squamous carcinoma after adjuvant concurrent radio-chemotherapy
Low RPMB might serve as a promising indicator for identifying suitable HNSC patients who might be medically fit for ACRT.
Authors
- Haijun Lu (ORCID: https://orcid.org/0000-0003-4733-5310)
- Xue Yang (ORCID: https://orcid.org/0000-0002-1659-7791)
- Yongchun Zhang (ORCID: https://orcid.org/0009-0009-9949-0604)
- Ning An (ORCID: https://orcid.org/0000-0002-8018-4238)
Institutions
- Qingdao University (CN)
- Affiliated Hospital of Qingdao University (CN)
Publication Details
- Journal
- Frontiers in Genetics
- Published
- 2025-06-11
- DOI
- https://doi.org/10.3389/fgene.2025.1585970
- Citations
- 1
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.85
Funders
- National Natural Science Foundation of China